Related Experiment Videos
Editorial overview. Biomarker-enabled drug discovery: bridging the gap between disease and target knowledge
Current Opinion in Investigational Drugs (London, England : 2000)
|July 2, 2004
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
EADB: an estrogenic activity database for assessing potential endocrine activity.
Toxicological sciences : an official journal of the Society of Toxicology·2013
'Impedance matching' of data sets in biomarker research.
Current opinion in investigational drugs (London, England : 2000)·2010
Reassessing the validity of surrogate markers of drug efficacy in the treatment of coronary artery disease.
Current opinion in investigational drugs (London, England : 2000)·2009
Metabolomic analyses of body fluids after subchronic manganese inhalation in rhesus monkeys.
Toxicological sciences : an official journal of the Society of Toxicology·2008
Application of the Cytosensor microphysiometer to drug discovery.
Receptors & channels·2003
Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?
Current opinion in investigational drugs (London, England : 2000)·2011
Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.
Current opinion in investigational drugs (London, England : 2000)·2010
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.
Current opinion in investigational drugs (London, England : 2000)·2010
Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.
Current opinion in investigational drugs (London, England : 2000)·2010
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.
Current opinion in investigational drugs (London, England : 2000)·2010
Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.
Current opinion in investigational drugs (London, England : 2000)·2010
Targeting Nonclassical Monocytes via Artificial Cell-Microneedles for Precision Psoriasis Therapy.
Advanced materials (Deerfield Beach, Fla.)·2026
Trends in Meningioma Incidence, Treatment, and Imaging Surveillance.
JAMA oncology·2026
Novel Use of Mavacamten in RAF1-Associated Noonan Syndrome With Hypertrophic Cardiomyopathy.
JACC. Case reports·2026
Functional and Anatomic Outcomes at 12 Months After Switching to Faricimab in Treatment-Recalcitrant Neovascular Age-Related Macular Degeneration.
Journal of vitreoretinal diseases·2026